World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 3 April 2017
Main ID:  ISRCTN26733572
Date of registration: 14/03/2017
Prospective Registration: No
Primary sponsor: Samnium Medical Cooperative
Public title: Effects of chia seeds on acne
Scientific title: Effects of CHIA SEED based nutraceutical products on ACNE lesions plaques in a randomised trial
Date of first enrolment: 23/02/2017
Target sample size: 150
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN26733572
Study type:  Interventional
Study design:  Open interventional parallel randomised controlled trial (Prevention)  
Phase: 
Countries of recruitment
Italy
Contacts
Name: Gian Carlo    Tenore
Address:  Via Domenico Montesano, 49 80131 Naples Italy
Telephone: +39081678610
Email: giancarlo.tenore@unina.it
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Men and women between 18-65 years of age
2. Caucasian
3. Chronic acne lesions of any severity (treated and untreated)

Exclusion criteria: 1. Smoking
2. Obesity (BMI >30 kg/m2)
3. Diabetes
4. Hepatic disease
5. Renal disease
6. Heart disease
7. Family history of chronic diseases
8. Heavy physical exercise (>10 h/week)
9. Pregnant women, women suspected of being pregnant, women who hoped to become pregnant, breastfeeding
10. Birch pollen allergy
11. Use of vitamin/mineral supplements 2 weeks prior to entry into the study
12. Donation of blood less than 3 months before the study


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Acne lesions
Skin and Connective Tissue Diseases
Acne lesions
Intervention(s)
Participants are asked to fill out a food frequency questionnaire at the beginning of the study. Participants in all groups eat a placebo daily for one month. Participants are then randomly allocated into one of five groups.

Group 1: Participants are instructed to consume five grams of chia seeds per day for two months.
Group 2: Participants are instructed to consume five grams micronized chia seeds per day for two months.
Group 3: Participants are instructed to consume two grams of monocomponent chia seed based nutraceutical (similar to a food supplement) per day for two months.
Group 4: Participants are instructed to consume two grams of multicomponent chia seed based nutraceutical (similar to a food supplement) per day for two months.
Group 5: Participants are instructed to consume 60 milligrams of vitamin E per day for two months.

Participants are followed up with blood tests and food frequency questionnaires after 4, 6, 8, 12 and 16 weeks (in which they are asked to fast for 12 hours before the test) to see if eating chia seeds impacts their acne severity.
Primary Outcome(s)
Severity of acne lesions are measured using the Global Acne Grading System (GAGS) score at baseline and 16 weeks.
Secondary Outcome(s)
1. Clinical history is measured both by interviews and previous clinical data at baseline
2. Itchiness is measured using Visual Analogue Scale (VAS) at baseline, 4, 8, 12, and 16 weeks
3. Nutrient intake and dietary habits are measured using a seven day food record validated nutritional questionnaire at baseline, 4, 8, 12, and 16 weeks
4. Blood pressure is measured using a blood pressure cuff at baseline, 4, 8, 12, and 16 weeks
5. 24 hour ambulatory blood pressure is measured using blood pressure cuff baseline, 4, 8, 12, and 16 weeks
6. Blood analysis (AST, ALT, ?-GTP, ALP, LDH, Albumin, Total bilirubin, Creatinine) is measured using a blood test (analysis by a spectrophotometer) at baseline, 4, 8, 12, and 16 weeks
Secondary ID(s)
19.04.2016 57994
Source(s) of Monetary Support
Samnium Medical Cooperative
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history